Online citations, reference lists, and bibliographies.
← Back to Search

Nasal Delivery Of Epitope Based Vaccines.

W. Olszewska, M. Steward
Published 2001 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Essentially all of the currently available vaccines are based on the use of inactivated or live-attenuated pathogens. However, these vaccines have several shortcomings, such as difficulties of in vitro culturing, biohazard risks, as well as loss of efficacy due to the genetic variations seen in many viruses. These problems may potentially be solved by immunising with epitope-based vaccines consisting of rationally designed protective epitopes, appropriately presented and easy to deliver, which are capable of stimulating effective B-cell, T-cell and cytotoxic immune responses whilst avoiding potentially hazardous and undesirable effects. Furthermore, the use of a mixture of defined epitopes could lead to an effective broad range immune response which has the potential to overcome both strain specificity of the pathogen and the MHC restriction of the host. Epitope-based vaccines can be designed to involve the use of synthetic materials that can be available in unlimited quantities and posing no biohazard. Other approaches include the use of naked DNA or recombinant viruses or bacteria expressing the epitopes. An important objective in the development of such vaccines is that they should be effective when delivered via the mucosal route and effective in the presence of maternal antibodies. In this review, we present examples of the use of various epitope-based vaccine constructs, focussing particularly upon their intranasal delivery to the immune system.
This paper references
Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.
J. Bowen (1994)
10.1128/IAI.63.3.934-939.1995
Induction of humoral immune response against Plasmodium falciparum sporozoites by immunization with a synthetic peptide mimotope whose sequence was derived from screening a filamentous phage epitope library.
J. Stoute (1995)
10.1002/EJI.1830200304
Identification of two promiscuous T cell epitopes from tetanus toxin
P. C. Ho (1990)
10.1128/JVI.65.4.1695-1700.1991
Measles virus nucleocapsid protein protects rats from encephalitis.
B. Bankamp (1991)
Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
R. V. van Binnendijk (1989)
10.1006/VIRO.2000.0285
Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
W. Olszewska (2000)
10.1128/JVI.69.3.1420-1428.1995
Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
O. Obeid (1995)
10.1046/j.1365-2567.1996.d01-790.x
The adjuvant effect of a non‐toxic mutant of heat‐labile enterotoxin of Escherichia coli for the induction of measles virus‐specific CTL responses after intranasal co‐immunization with a synthetic peptide
C. Partidos (1996)
10.1128/JVI.67.4.2276-2284.1993
Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein.
R. V. van Binnendijk (1993)
Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant.
Z. Xiang (1999)
10.1006/VIRO.1993.1598
Expression of an animal virus antigenic site on the surface of a plant virus particle.
R. Usha (1993)
10.1099/0022-1317-79-11-2709
The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope.
E. Buratti (1998)
10.1159/000150478
The development of cowpea mosaic virus as a potential source of novel vaccines.
C. Porta (1996)
10.1007/978-3-642-78530-6_9
Cytotoxic T lymphocyte responses against measles virus.
F. Uytdehaag (1994)
10.1016/0264-410X(95)00241-R
Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization.
S. C. Hsu (1996)
10.1016/S0264-410X(97)88326-0
Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen.
L. Hathaway (1998)
10.1016/S0264-410X(94)80062-5
Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses.
B. Nardelli (1994)
10.1128/IAI.68.9.4923-4929.2000
Antipeptide Antibody Responses following Intranasal Immunization: Effectiveness of Mucosal Adjuvants
W. Olszewska (2000)
Development of a recombinant vaccinia-rabies vaccine for oral vaccination of foxes against rabies.
P. Pastoret (1992)
10.1099/0022-1317-73-8-1987
The effects of a flanking sequence on the immune response to a B and a T cell epitope from the fusion protein of measles virus.
C. Partidos (1992)
10.1073/PNAS.86.23.9084
Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes.
J. P. Tam (1989)
10.1007/s007050170176
Immune responses and protection induced by mucosal and systemic immunisation with recombinant measles nucleoprotein in a mouse model of measles virus-induced encephalitis
W. Olszewska (2001)
10.1002/j.1460-2075.1994.tb06501.x
A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera.
A. Folgori (1994)
10.1038/372552A0
Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi
S. Langermann (1994)
10.1006/JMBI.1997.1407
The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes.
A. Young (1997)
10.1128/JVI.71.3.2292-2302.1997
A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
L. L. An (1997)
10.1128/IAI.67.9.4679-4688.1999
Isolation of Peptides That Mimic Epitopes on a Malarial Antigen from Random Peptide Libraries Displayed on Phage
C. Adda (1999)
10.1006/VIRO.1993.1179
Identification of HIV vaccine candidate peptides by screening random phage epitope libraries.
P. Keller (1993)
10.1006/VIRO.1996.0230
Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
P. Beauverger (1996)
10.1016/0264-410X(94)90112-0
New strategies for using mucosal vaccination to achieve more effective immunization.
R. Walker (1994)
10.1001/JAMA.1983.03330430027025
Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.
A. Sabin (1983)
10.1128/JVI.73.2.930-938.1999
Chimeric Plant Virus Particles Administered Nasally or Orally Induce Systemic and Mucosal Immune Responses in Mice
F. R. Brennan (1999)
Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes.
S. Chai (1992)
10.1016/S0952-7915(99)80033-8
Exploring immunological specificity using synthetic peptide combinatorial libraries.
C. Pinilla (1999)
10.1089/AID.1995.11.327
Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus.
L. McLain (1995)
10.1016/S0022-1759(98)00145-8
Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
Z. Durrani (1998)
10.1006/VIRO.1996.0012
Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
C. Partidos (1996)
10.1006/VIRO.1997.8923
Reduction of respiratory syncytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide.
S. C. Hsu (1998)
10.1016/0168-1702(96)01311-1
Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.
O. Obeid (1996)
10.1073/PNAS.85.15.5409
Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.
J. P. Tam (1988)
10.1128/JVI.69.12.7668-7673.1995
A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response.
M. Steward (1995)
10.1038/NBT0397-248
Plant–derived vaccine protects target animals against a viral disease
K. Dalsgaard (1997)
10.1073/PNAS.91.20.9588
A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years.
H. Naruse (1994)
10.1006/VIRO.1994.1417
Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides.
C. Porta (1994)
Potential of chimaeric plant virus particles as novel, stable vaccines.
F. Xu (1996)
10.1016/0264-410X(95)00229-T
Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus.
L. McLain (1996)
10.1016/0264-410X(95)00111-D
Induction of systemic immune responses to measles virus synthetic peptides administered intranasally.
L. Hathaway (1995)
10.3109/10611869609015965
Nasal delivery of vaccines.
A. Almeida (1996)
10.1128/IAI.64.9.3833-3844.1996
NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.
J. Tine (1996)
10.1089/AID.1997.13.881
Mucosal immune response to an HIV C4/V3 peptide following nasal or intestinal immunization of rabbits.
J. Winchell (1997)
10.1073/PNAS.89.9.3879
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
J. P. Defoort (1992)
10.1002/EJI.1830221030
The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides
C. Partidos (1992)
Lack of age-associated immune dysfunction in mucosal-associated lymph nodes.
M. Szewczuk (1981)
10.1016/S0165-2478(97)00045-X
Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein.
D. Chargelegue (1997)
10.1016/S0065-2776(08)60585-4
The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases.
E. Nardin (1995)
10.1099/0022-1317-71-9-2099
Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans.
C. Partidos (1990)



This paper is referenced by
10.1093/BMB/62.1.99
Development of vaccines against common colds.
W. Olszewska (2002)
10.1016/S0065-3527(02)58003-9
The potential of plant viral vectors and transgenic plants for subunit vaccine production.
P. Awram (2002)
10.1016/j.bbrc.2010.04.133
Design and evaluation of a multi-epitope peptide against Japanese encephalitis virus infection in BALB/c mice.
J. Wei (2010)
Evaluation of intranasal canine parvovirus vaccination in dogs
Murugesan (2010)
10.3390/molecules14093754
Nasal Delivery of High Molecular Weight Drugs
Y. Ozsoy (2009)
10.1016/j.vaccine.2008.08.035
Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus.
Peng Li (2008)
10.1186/1743-422X-9-204
Multiple linear epitopes (B-cell, CTL and Th) of JEV expressed in recombinant MVA as multiple epitope vaccine induces a protective immune response
Feng-Juan Wang (2011)
10.1016/j.vetimm.2015.05.005
Construction of Eimeria tenella multi-epitope DNA vaccines and their protective efficacies against experimental infection.
Xiaokai Song (2015)
10.1002/9780470688618.TAW0121
New Approaches to Vaccine Delivery
C. Partidos (2010)
10.1016/j.cellimm.2013.01.005
The dominant roles of ICAM-1-encoding gene in DNA vaccination against Japanese encephalitis virus are the activation of dendritic cells and enhancement of cellular immunity.
Y. Zhai (2013)
10.1007/s13238-015-0164-2
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
S. Wang (2015)
10.1016/j.tvjl.2008.09.019
Enhancement of humoral and cellular immunity in mice against Japanese encephalitis virus using a DNA prime-protein boost vaccine strategy.
P. Li (2010)
10.1016/j.vetmic.2013.02.010
Construction and immunogenicity evaluation of an epitope-based antigen against swine influenza A virus using Escherichia coli heat-labile toxin B subunit as a carrier-adjuvant.
Z. Sun (2013)
Semantic Scholar Logo Some data provided by SemanticScholar